New study aims to map social challenges in rare genetic syndrome

NCT ID NCT07469566

First seen Jun 24, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This study will follow 15 people aged 5 to 50 with 7q11.23 microduplication syndrome, a rare genetic condition linked to autism and social difficulties. Researchers will track developmental milestones, social skills, and behavior using interviews and questionnaires. The goal is to better understand how social impairments change over time, which could help design future treatment trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could identify key developmental milestones and outcome measures needed to design future clinical trials for potential treatments.
What could go wrong
This is an observational study with only 15 participants, so findings may not apply to everyone with the syndrome. It does not test any treatment directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for 7Q11.23 MICRODUPLICATION SYNDROME (7DUP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Developmental Anomalies Reference Center, Genetics Department Woman Mother and Child Hospital, University Hospital of Lyon, Hospices Civils de Lyon

    RECRUITING

    Bron, 69677, France

  • Reference Center of Rare Disease with Intellectual Disability- in Lyon, Woman Mother and Child Hospital, University Hospital of Lyon, Hospices Civils de Lyon

    RECRUITING

    Bron, 69677, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.